Recent Quotes
My Watchlist
Indicators
Local Stocks
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Champions Oncolog (NQ: CSBR )

4.260 +0.170 (+4.16%)
Streaming Delayed Price Updated: 3:31 PM EST, Nov 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 17,358
Open 4.170
Bid (Size) 4.260 (2)
Ask (Size) 4.400 (5)
Prev. Close 4.090
Today's Range 4.120 - 4.580
52wk Range 3.600 - 7.130
Shares Outstanding 13,415,066
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Champions Oncology Announces Agreement with Weill Cornell Medicine
Via ACCESSWIRE
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Performance

YTD
-26.42%
-26.42%
1 Month
-8.78%
-8.78%
3 Month
-5.33%
-5.33%
6 Month
-12.35%
-12.35%
1 Year
-24.06%
-24.06%

More News

Read More
Kroger, Adobe And 3 Stocks To Watch Heading Into Thursday
Via Benzinga
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million
Via ACCESSWIRE
A Preview Of Champions Oncology's Earnings
Via Benzinga
Champions Oncology Reports Quarterly Revenue of $14.0 Million
Via ACCESSWIRE
Champions Oncology: Q3 Earnings Insights
Via Benzinga
Earnings Outlook For Champions Oncology
Via Benzinga
Recap: Champions Oncology Q2 Earnings
Via Benzinga
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024
Via ACCESSWIRE
CSBR Stock Earnings: Champions Oncology Beats EPS, Beats Revenue for Q4 2024
Via InvestorPlace
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
Via ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.0 Million
Via ACCESSWIRE
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
Via ACCESSWIRE
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
Via ACCESSWIRE
Earnings Scheduled For March 12, 2024
Via Benzinga
Insiders Buying Solid Biosciences And 2 Other Stocks
Via Benzinga
Insiders Buying Tilly's And 2 Other Stocks
Via Benzinga
Why Is RiskOn International (ROI) Stock Up 28% Today?
Via InvestorPlace
CSBR Stock Earnings: Champions Oncology Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Champions Oncology Reports Quarterly Revenue of $11.6 Million
Via ACCESSWIRE
Earnings Scheduled For December 12, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.